214 related articles for article (PubMed ID: 31172910)
1. In vitro efficacy of sodium selenite in reducing toxin production, spore outgrowth and antibiotic resistance in hypervirulent Clostridium difficile.
Pellissery AJ; Vinayamohan PG; Yin HB; Mooyottu S; Venkitanarayanan K
J Med Microbiol; 2019 Jul; 68(7):1118-1128. PubMed ID: 31172910
[TBL] [Abstract][Full Text] [Related]
2. Carvacrol reduces Clostridium difficile sporulation and spore outgrowth in vitro.
Mooyottu S; Flock G; Venkitanarayanan K
J Med Microbiol; 2017 Aug; 66(8):1229-1234. PubMed ID: 28786786
[TBL] [Abstract][Full Text] [Related]
3.
Pellissery AJ; Vinayamohan PG; Venkitanarayanan K
J Med Microbiol; 2020 Apr; 69(4):631-639. PubMed ID: 32216868
[No Abstract] [Full Text] [Related]
4. Association of Fidaxomicin with C. difficile Spores: Effects of Persistence on Subsequent Spore Recovery, Outgrowth and Toxin Production.
Chilton CH; Crowther GS; Ashwin H; Longshaw CM; Wilcox MH
PLoS One; 2016; 11(8):e0161200. PubMed ID: 27556739
[TBL] [Abstract][Full Text] [Related]
5. Toxin production of Clostridium difficile in sub-MIC of vancomycin and clindamycin alone and in combination with ceftazidime.
Zarandi ER; Mansouri S; Nakhaee N; Sarafzadeh F; Moradi M
Microb Pathog; 2017 Jun; 107():249-253. PubMed ID: 28286152
[TBL] [Abstract][Full Text] [Related]
6. Fidaxomicin reduces early toxin A and B production and sporulation in Clostridium difficilein vitro.
Aldape MJ; Packham AE; Heeney DD; Rice SN; Bryant AE; Stevens DL
J Med Microbiol; 2017 Oct; 66(10):1393-1399. PubMed ID: 28893366
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the effect of oritavancin on Clostridium difficile spore germination, outgrowth and recovery.
Chilton CH; Freeman J; Baines SD; Crowther GS; Nicholson S; Wilcox MH
J Antimicrob Chemother; 2013 Sep; 68(9):2078-82. PubMed ID: 23759507
[TBL] [Abstract][Full Text] [Related]
8. Sub-lethal doses of surotomycin and vancomycin have similar effects on Clostridium difficile virulence factor production in vitro.
Aldape MJ; Rice SN; Field KP; Bryant AE; Stevens DL
J Med Microbiol; 2018 Dec; 67(12):1689-1697. PubMed ID: 30307842
[TBL] [Abstract][Full Text] [Related]
9. Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production.
Merrigan M; Venugopal A; Mallozzi M; Roxas B; Viswanathan VK; Johnson S; Gerding DN; Vedantam G
J Bacteriol; 2010 Oct; 192(19):4904-11. PubMed ID: 20675495
[TBL] [Abstract][Full Text] [Related]
10. Oritavancin does not induce Clostridium difficile germination and toxin production in hamsters or a human gut model.
Freeman J; Marquis M; Crowther GS; Todhunter SL; Fawley WN; Chilton CH; Moeck G; Lehoux D; Wilcox MH
J Antimicrob Chemother; 2012 Dec; 67(12):2919-26. PubMed ID: 22899803
[TBL] [Abstract][Full Text] [Related]
11. Effect of sub-MIC concentrations of metronidazole, vancomycin, clindamycin and linezolid on toxin gene transcription and production in Clostridium difficile.
Gerber M; Walch C; Löffler B; Tischendorf K; Reischl U; Ackermann G
J Med Microbiol; 2008 Jun; 57(Pt 6):776-783. PubMed ID: 18480337
[TBL] [Abstract][Full Text] [Related]
12. Outcome of relapsing Clostridium difficile infections do not correlate with virulence-, spore- and vegetative cell-associated phenotypes.
Plaza-Garrido Á; Miranda-Cárdenas C; Castro-Córdova P; Olguín-Araneda V; Cofré-Araneda G; Hernández-Rocha C; Carman R; Ibáñez P; Fawley WN; Wilcox MH; Gil F; Calderón IL; Fuentes JA; Guzmán-Durán AM; Alvarez-Lobos M; Paredes-Sabja D
Anaerobe; 2015 Dec; 36():30-8. PubMed ID: 26403333
[TBL] [Abstract][Full Text] [Related]
13. Tigecycline suppresses toxin A and B production and sporulation in Clostridium difficile.
Aldape MJ; Heeney DD; Bryant AE; Stevens DL
J Antimicrob Chemother; 2015 Jan; 70(1):153-9. PubMed ID: 25151204
[TBL] [Abstract][Full Text] [Related]
14. Effects of surotomycin on Clostridium difficile viability and toxin production in vitro.
Bouillaut L; McBride S; Sorg JA; Schmidt DJ; Suarez JM; Tzipori S; Mascio C; Chesnel L; Sonenshein AL
Antimicrob Agents Chemother; 2015 Jul; 59(7):4199-205. PubMed ID: 25941230
[TBL] [Abstract][Full Text] [Related]
15. Time-resolved transcriptome analysis of Clostridium difficile R20291 response to cysteine.
Gu H; Shi K; Liao Z; Qi H; Chen S; Wang H; Li S; Ma Y; Wang J
Microbiol Res; 2018 Oct; 215():114-125. PubMed ID: 30172297
[TBL] [Abstract][Full Text] [Related]
16. The Transcriptional Regulator Lrp Contributes to Toxin Expression, Sporulation, and Swimming Motility in
Chen KY; Rathod J; Chiu YC; Chen JW; Tsai PJ; Huang IH
Front Cell Infect Microbiol; 2019; 9():356. PubMed ID: 31681632
[No Abstract] [Full Text] [Related]
17. Inhibitory effect of REP3123 on toxin and spore formation in Clostridium difficile, and in vivo efficacy in a hamster gastrointestinal infection model.
Ochsner UA; Bell SJ; O'Leary AL; Hoang T; Stone KC; Young CL; Critchley IA; Janjic N
J Antimicrob Chemother; 2009 May; 63(5):964-71. PubMed ID: 19251726
[TBL] [Abstract][Full Text] [Related]
18. Revisiting the Role of Csp Family Proteins in Regulating Clostridium difficile Spore Germination.
Kevorkian Y; Shen A
J Bacteriol; 2017 Nov; 199(22):. PubMed ID: 28874406
[No Abstract] [Full Text] [Related]
19. Reexamining the Germination Phenotypes of Several Clostridium difficile Strains Suggests Another Role for the CspC Germinant Receptor.
Bhattacharjee D; Francis MB; Ding X; McAllister KN; Shrestha R; Sorg JA
J Bacteriol; 2015 Dec; 198(5):777-86. PubMed ID: 26668265
[TBL] [Abstract][Full Text] [Related]
20. Effects of ciprofloxacin on the expression and production of exotoxins by Clostridium difficile.
Aldape MJ; Packham AE; Nute DW; Bryant AE; Stevens DL
J Med Microbiol; 2013 May; 62(Pt 5):741-747. PubMed ID: 23429695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
